Denali Therapeutics Inc.

NYSE
DNLI
Stock
Yield per half year: -35.08%
Dividend yield: 0%
Sector: Healthcare

Denali Therapeutics Inc.

36.0036.0030.0030.0024.0024.0018.0018.0012.0012.006.006.00Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
62.94 52.65 19.55% 30.35 +107.38%
P/S 9.13 4.03 126.32%
P/BV 2.71 10.87 -75.09%
P/FCF -8.53 39.64 -121.51%
Ev/Ebitda -7.72 16.12 -147.9%
Ev/S 9.69 4.35 122.67%
Ev/FCF -8.81 52.31 -116.84%
E/P -0.1364 0.2095 -165.12%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-125.53 19.07 -758.22% -214.73 -41.54%
ROE -37.4 -83.32 -55.11%
ROA -33.45 6.38 -624.34%
ROIC 0 15.06 -100%
ROS -127.91 9.34 -1470.19%
ROCE -16 67.03 -123.87%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.1174 1.02 -111.53% -0.1869 -37.17%
Nеt Debt/Ebitda 0.3043 1.4 -78.26%
Debt/Ratio 0.0354 0.2741 -87.07%
Debt/Equity 0.1175 13.6 -99.14%
Debt/Net Income -0.1152 6.8 -101.69%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.28 -100% 0 0%
Number of years of dividend growth 0 6.75 -100%
DSI 0 0.7413 -100%
Average dividend growth 0 -4.1 -100%
Average percentage for 5 years 0 1.34 -100%
Average percentage for payments 0 44.08 -100%
Difference from average difference in sector -1.28

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
1137.94 12.47 9025.42%
Growth impulse Ebitda in 5 years -761.74 -86.3 782.67%
Growth impulse Net Income in 5 years -694.62 -75.86 815.66%
Growth impulse FCF in 5 years -188.02 -79.28 137.16%
Growth impulse EPS in 5 years -507.23 4.34 -11787.33%
IP Score
3.28/10

Similar companies

UnitedHealth Group

Humana

Bristol-Myers

PerkinElmer

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription